PART I: IPEC-Americas Excipient World 2024May 13-15, 2024 - Orlando, FL, USA |
 |
PART II: CRS 2024 Annual Meeting and ExpositionJuly 8-12, 2024 - Bologna, Italy |
 |
The increasing pressures on global healthcare systems, exacerbated by the recent pandemic, underscore the need to enhance drug delivery in decentralized settings. These settings encompass dosing in clinics, physician offices, community centers, as well as at-home and self-administration, thus considering individual preferences and capabilities. A reduction in dosing frequency to limit in-clinic visits is also part of this strategy and is expected to improve access to medications, particularly in countries with limited healthcare infrastructures and rural regions.
Especially for biotherapeutics requiring parenteral administration, dosing regimens are typically complex, requiring close supervision by professional caregivers.
Drug delivery scientists and device engineers play a crucial role in realizing the broad applicability and affordability of novel drug delivery devices. Close collaboration with regulators, payers, healthcare providers, and patients is necessary to co-create customer-centric devices that meet the needs of a broader population.
The symposium will feature experts from the pharmaceutical industry, biotech companies, and academia sharing insights into the latest status of drug delivery devices. Administration routes discussed will include subcutaneous and intravitreal dosing, inhalation devices, as well as oral delivery.
Participants will learn about challenges and opportunities associated with various device types, be introduced to the regulatory framework underlying the approval process, understand user preferences and co-creation approaches, and explore novel clinical development approaches.
9:00 AM - 9:10 AM
Opening & Overview of Drug Delivery Devices
Simon Matoori, PhD, Université de Montréal
9:10 AM - 9:15 AM
The Role of Drug Delivery Devices in Enabling Access Through Decentralized Care
Beate Bittner, PhD, F. Hoffmann - La Roche Ltd
9:15 AM - 9:35 AM
Recent Developments with Devices for Intravitreal Injection
Eva Rosenberg, PhD, F. Hoffmann - La Roche Ltd
9:35 AM - 9:55 AM
Implantable Polymeric Systems for Treating Brain Tumors and Osteoarthritis
Annalisa Palange, PhD, Istituto Italiano di Tecnologia
9:55 AM - 10:15 AM
High-Volume Subcutaneous Injection Devices - Pushing the Injection Volume Boundaries
David Kang, PhD, Halozyme
10:15 AM - 10:35 AM
High-Volume Subcutaneous Injection Devices - Pushing the Injection Volume Boundaries
Ron Pettis, MS, PhD, Becton Dickinson
10:35 AM - 10:55 AM
The Role of Connected Subcutaneous Devices in Enhancing Access to Treatment
Beate Bittner, PhD, F. Hoffmann - La Roche Ltd
10:55 am - BREAK
11:15 AM - 12:00 PM
Oral Delivery of Biotherapeutics - Changing the Drug Delivery Paradigm
Giovanni Traverso, MB, BChir, PhD, Massachusetts Institute of Technology (MIT)
12:00 PM - BREAK
1:00 PM - 1:15 PM
Wrap-up for Biologics Summit Part I
Nigel Langley, PhD, MBA, FRSC, Gaylord Chemical & IPEC-Americas
1:15 PM - 1:25 PM
Skin and Mucosa Focus Group Industry Sub-Team
1:25 PM - 1:45 PM
Regulatory Aspects of Device development
Paola Minghetti, Università degli Studi di Milano
1:45 PM - 2:15 PM
Panel Discussion
Moderator: Simon Matoori, Université de Montréal
2:15 PM - 2:20 PM
Closing Remarks
Simon Matoori, Université de Montréal & Beate Bittner, F. Hoffmann - La Roche Ltd
